Related Experiment Video

Updated: Aug 16, 2026

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
10:00

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

Published on: March 24, 2015

Influence of HLA-DRB1 alleles and HBV genotypes on interferon-alpha therapy for chronic hepatitis B

Rui-Hai Chu1, Li-Xian Ma, Gang Wang

  • 1Department of Infectious Diseases, Qilu Hospital of Shandong University, Jinan, Shandong Province, China. rhchu@163.com

World Journal of Gastroenterology
|August 12, 2005
PubMed

Insights

The HLA-DRB1*07 allele and Hepatitis B virus (HBV) genotype C are linked to lower effectiveness of interferon-alpha treatment in chronic hepatitis B patients.

Area of Science:

  • Immunogenetics
  • Virology
  • Hepatology

Background:

  • Chronic hepatitis B (CHB) is a significant global health concern.
  • Interferon-alpha (IFN-α) therapy is a treatment option for CHB, but response rates vary.
  • Host genetic factors, such as Human Leukocyte Antigen (HLA) alleles, and viral factors, like HBV genotypes, may influence treatment outcomes.

Purpose of the Study:

  • To examine the association between specific HLA-DRB1 alleles, HBV genotypes, and the efficacy of interferon-alpha therapy in patients with chronic hepatitis B.
  • To identify potential genetic markers that predict response to IFN-α treatment in CHB.

Main Methods:

  • HLA-DRB1 alleles were genotyped using polymerase chain reaction/sequence specific primer (PCR/SSP) in 126 CHB patients and 76 controls.
  • Hepatitis B virus (HBV) genotypes were determined by nested-PCR analysis in the patient cohort.
  • Patient response to interferon-alpha therapy was assessed and correlated with HLA and HBV genotypes.

Main Results:

  • The HLA-DRB1*07 allele was found at a significantly higher frequency in CHB patients compared to controls (P<0.025).
  • Among the CHB patients, HBV genotypes B and C were prevalent (30.2% and 54.8%, respectively), with no genotypes D-F detected.
  • Patients positive for HLA-DRB1*07 and those with HBV genotype C showed significantly higher rates of non-response to interferon-alpha therapy (P<0.05).

Conclusions:

  • The presence of the HLA-DRB1*07 allele and HBV genotype C are significantly associated with reduced responsiveness to interferon-alpha treatment in chronic hepatitis B.
  • These findings suggest that host and viral genetic factors play a crucial role in determining the effectiveness of IFN-α therapy for CHB.
Abstract

More Related Videos

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...